Financial stocks

5 Reasons You Shouldn’t Fear Buying Big, Bad Banks

There are plenty of reasons to fear bank stocks right now, but there are also plenty of opportunities for investors brave enough to step up to the plate.

Selloff in Pharma United Therapeutics and Exelixis

Volume leaders in midday trading included Credicorp (NYSE: BAP), Lorillard (NYSE: LO), United Therapeutics Corp. (NASDAQ: UTHR).

How Serious Was This Sell-off?

Was yesterday’s massive decline a one-day phenomenon, or a warning that the market is headed lower?

What Will It Take to Keep This Rally Going?

If the major indices can muster another close above their 50-day moving averages the path of least resistance will remain to the upside.

6 Unpopular Bank Stocks to Sell

Investors have not shown these financials much love, and that is unlikely to change in the near future.

Should You Follow Buffett Into MasterCard?

MasterCard's (NYSE:MA) PEG of 1.07 is a reasonable value. Its P/E is 18.8 and MasterCard's earnings are expected to grow 17.5% in 2012 to $19.99 a share. With Buffett's backing and the real chance that it can sustain a higher earnings growth rate based on its performance over the last five years, buying MasterCard stock could be a profitable addition to your portfolio.